'Pharma Bro' Martin Shkreli's Trial Begins
Former pharmaceutical CEO Martin Shkreli goes on trial starting Monday for federal securities fraud. Shkreli, who became known as “pharma bro,” came under widespread criticism for upping the price of the lifesaving drug Daraprim 5,000 percent. He is going on trial for something unrelated — prosecutors say that he operated a Ponzi-like scheme at two companies he ran.
Copyright 2021 NPR. To see more, visit https://www.npr.org.